Sector
Food processing
Healthcare
Industry
Food & Food Tech
Pharma
Business model
B2B
B2C
Technology
Biotechnology
Location
Ernakulam, Kerala
Founded
2026
Team
Sandra Santhosh
Co-founder
Products 4
Select one to read more
Atlantis Fish Oil
Fish oil separated from fish by-products in our protein and oil line. Pilot sample: free fatty acids 2.94%, moisture 0.4%. Intended as a human-grade ingredient for nutrition and supplement makers (B2B). Process standardised; quality specifications being confirmed.
- The gap: oil is often recovered as a low-value by-product of fish meal production. Fresh, cold-chain raw material protects its quality.
- Industry: Nutrition and supplement manufacturers. Crude Fish oil in Kerala is typically produced at fish meal plants an older ICAR study put output at about 34,000 tonnes a year across Karnataka, Kerala and Tamil Nadu. But the human grade fish oil is imported into india either as high grade fish oil raw material or as end products.
- Uniqueness:
- oil recovered from fresh, cold-chain by-products in a line designed to produce several products together, aimed at human grade. Sustainable fish by-products processing
- Co-developed with ICAR-CIFT
- Process improvements:
- Fresh raw material through a controlled cold chain aimed at human grade fish oil production.
- Oil is separated in the same line that makes hydrolysate, so it does not need its own processing.
- Pilot proof : free fatty acids 2.94%, moisture 0.4%.
- Impact:
- Upgrades a low-value stream into a higher-value ingredient.
- Adds revenue per tonne of by-products without extra raw material.
- Supports domestic fish oil supply (human grade).
Sector
Food processing
Industry
Food & Food Tech
Model
B2B
Technology
Biotechnology
Atlantis Fish Collagen / Gelatin Peptide
Human-grade collagen peptide and food and pharma-grade gelatin peptides from Kerala fish processing by-products. Pilot sample: 96.3% protein, 0.93% ash. B2B to nutrition, supplement, food and pharma makers. Process standardised; pilot validation under way.
- The gap: Collagen/gelatin peptides are made mainly from fish scales, because other by-product parts give strong odor and taste. Scale supply is limited, so the raw material base is narrow.
- Industry: Nutraceuticals and supplements, food and beverage, pharma, and cosmetics. India’s marine hydrolyzed collagen market was USD 107.7 million in 2025. Globally, marine collagen is forecast to roughly double by 2034, at about 7.2% a year. Bulk peptides are largely imported from China, the USA and Norway.
- Uniqueness:
- a process designed to obtain collagen /gelatin peptides of acceptable sensory quality, with raw material quality controlled from collection onward.
- Non - Conventional raw materials for collagen and Gelatin peptide.
- Co-developed with ICAR-CIFT
- Process improvements:
- Cold-chain collection and segregation by tissue type.
- Total Valorisation.
- Collagen, bio calcium, hydrolysate and fish oil come from one stream, which lowers the cost per product.
- Pilot proof : protein 96.3%, moisture 9.1%, fat 1%, ash 0.93%.
- Impact:
- Reduces dependence on imported peptides and scales.
- Moves by-products from low-value into high-value use.
- Stage and next: process standardised; pilot validation under way. Next: sensory and safety testing, FSSAI requirements, IP filing.
Sector
Food processing
Industry
Food & Food Tech
Model
B2B
Technology
Biotechnology
Atlantis Fish Protein Hydrolysate
Fish protein hydrolysate powder from cold-chain fish by-products. Pilot sample: 98% protein, 1.35% ash, 1.18% fat. B2B to pet food makers ; the dietary replacement product is long-term R&D. Pilot validation under way, including palatability.
- The gap: Hydrolysates have documented nutritional benefits but limited use beyond feed, partly because of palatability, and quality supply depends on imports.
- Today’s market: India’s fish protein hydrolysate market is INR 550 to 700 crore (USD 65 to 85 million, 2026), with aquafeed at 55 to 60% of demand. Imports are 6,000 to 8,000 tonnes (INR 200 to 300 crore): feed grade mainly from Thailand, Vietnam and China, and bioactive grade from Norway and the USA .
- Improvements for the existing pet food industry:
Domestic supply from fresh, cold-chain raw material instead of imports.
Consistent, high-protein, low-ash quality (pilot: 98% protein, 1.35% ash).
A process designed to improve palatability, which is being validated.
Traceable Kerala sourcing, with cost shared across a multi-product line. - The dietary innovation (long-term R&D): a hydrolysate-based dietary replacement product from by-products or whole fish. It was inspired by a safety trial of a fish protein hydrolysate in malnourished schoolchildren near New Delhi, made from imported Atlantic salmon. The aim is an affordable, locally made alternative.
- Uniqueness:
- Made from fresh, cold-chain Kerala fish by-products, designed to be palatable.
- Positioned first for pet food, with long-term R&D toward a hydrolysate-based dietary replacement product from fish trimmings or whole fish.
- Co-Developed with ICAR-CIFT
- Impact:
- Substitutes part of the imported hydrolysate.
- Gives pet food and feed makers a domestic, traceable supplier.
- Long term, it targets affordable protein nutrition.
- Stage and next: process standardised; pilot validation under way working hand in hand with ICAR-CIFT , including palatability and safety.
Sector
Food processing
Industry
Food & Food Tech
Model
B2B
B2C
Technology
Biotechnology
Atlantis Bio Calcium
Calcium-rich mineral fraction recovered from fish bones in our collagen and calcium line. Pilot sample: 43.91% ash. Intended as a human-grade ingredient for supplement and nutrition makers (B2B). Process standardised; composition and human grade analysis to be confirmed.
- The gap: bones typically go to fish meal or fertiliser at low value, and their mineral fraction is untapped for nutrition.
- Industry: Dietary supplements and nutrition products, where calcium ingredients are a standard category. Supplements and nutraceuticals are also the largest segment for marine collagen, so the same customers buy both.
- Uniqueness:
- a calcium-rich mineral recovered in the same integrated line as collagen, so it is a co-product of the process and not a separate operation.
- Co-developed with ICAR-CIFT
- Process improvements:
- Bones are recovered from the same cold-chain stream, adding a revenue line from material otherwise lost.
- Pilot proof : protein 1.73%, moisture 49.16%, fat 0.085%, ash 43.91%.
- Impact:
- Adds a product from by-products, which supports full utilisation of the by-product stream.
- Supports a domestic source of a supplement ingredient.
- Stage and next: process standardised; pilot validation under way. Next: confirm the compound and specification, heavy metal and microbial testing, FSSAI route.
Sector
Healthcare
Industry
Pharma
Model
B2B
Technology
Biotechnology